Arteris, Inc. (NASDAQ:AIP – Get Free Report) CFO Nicholas Hawkins sold 3,000 shares of Arteris stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $37.75, for a total transaction of $113,250.00. Following the transaction, the chief financial officer owned 108,549 shares in the company, valued at approximately $4,097,724.75. This trade represents a 2.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Arteris Trading Down 0.1%
Shares of NASDAQ:AIP traded down $0.02 during mid-day trading on Thursday, reaching $36.92. 937,669 shares of the company’s stock were exchanged, compared to its average volume of 645,970. The firm has a market capitalization of $1.70 billion, a price-to-earnings ratio of -46.73 and a beta of 1.93. The business’s fifty day moving average price is $24.82 and its 200-day moving average price is $18.85. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.73 and a current ratio of 0.73. Arteris, Inc. has a twelve month low of $7.53 and a twelve month high of $38.47.
Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The business had revenue of $22.94 million for the quarter, compared to analyst estimates of $21.03 million. On average, research analysts predict that Arteris, Inc. will post -0.68 EPS for the current fiscal year.
Institutional Investors Weigh In On Arteris
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on AIP shares. Wall Street Zen lowered shares of Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. TD Cowen boosted their target price on shares of Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. Rosenblatt Securities boosted their target price on shares of Arteris from $20.00 to $38.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. Northland Securities set a $38.00 target price on shares of Arteris in a research report on Wednesday, May 13th. Finally, Weiss Ratings downgraded shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $37.75.
View Our Latest Stock Report on Arteris
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Read More
- Five stocks we like better than Arteris
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
